Cambridge Investment Research Advisors’s Strategy Shares Nasdaq 7HANDL Index ETF HNDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.74M Buy
426,309
+19,917
+5% +$451K 0.02% 692
2026
Q1
$8.88M Buy
406,392
+576
+0.1% +$12.8K 0.02% 658
2025
Q4
$8.94M Buy
405,816
+16,900
+4% +$375K 0.02% 627
2025
Q3
$8.66M Buy
388,916
+11,934
+3% +$261K 0.02% 632
2025
Q2
$8.16M Buy
376,982
+2,574
+0.7% +$53.6K 0.02% 628
2025
Q1
$7.9M Buy
374,408
+3,602
+1% +$77.2K 0.03% 596
2024
Q4
$7.91M Buy
370,806
+1,162
+0.3% +$25.5K 0.03% 583
2024
Q3
$8.22M Buy
369,644
+203
+0.1% +$4.39K 0.03% 574
2024
Q2
$7.8M Buy
369,441
+10,417
+3% +$216K 0.03% 559
2024
Q1
$7.62M Sell
359,024
-11,496
-3% -$239K 0.03% 557
2023
Q4
$7.66M Sell
370,520
-21,761
-6% -$425K 0.03% 516
2023
Q3
$7.5M Buy
392,281
+641
+0.2% +$12.8K 0.04% 477
2023
Q2
$7.96M Buy
391,640
+13,836
+4% +$279K 0.04% 460
2023
Q1
$7.64M Buy
377,804
+16,257
+4% +$328K 0.04% 451
2022
Q4
$7.08M Buy
361,547
+1,003
+0.3% +$19.8K 0.04% 468
2022
Q3
$6.92M Buy
360,544
+13,647
+4% +$290K 0.04% 430
2022
Q2
$7.15M Buy
346,897
+15,005
+5% +$331K 0.04% 440
2022
Q1
$8M Buy
331,892
+34,877
+12% +$848K 0.04% 457
2021
Q4
$7.72M Buy
297,015
+744
+0.3% +$19.1K 0.03% 474
2021
Q3
$7.39M Buy
296,271
+101,053
+52% +$2.59M 0.04% 453
2021
Q2
$5M Buy
195,218
+42,963
+28% +$1.09M 0.02% 617
2021
Q1
$3.77M Buy
152,255
+23,592
+18% +$593K 0.02% 687
2020
Q4
$3.29M Buy
128,663
+65,656
+104% +$1.64M 0.02% 677
2020
Q3
$1.55M Buy
63,007
+52,135
+480% +$1.29M 0.01% 935
2020
Q2
$262K Buy
10,872
+300
+3% +$7.01K ﹤0.01% 1986
2020
Q1
$233K Sell
10,572
-74,705
-88% -$1.77M ﹤0.01% 1837
2019
Q4
$2.08M Buy
85,277
+44,859
+111% +$1.08M 0.02% 774
2019
Q3
$976K Buy
40,418
+2,224
+6% +$53.7K 0.01% 1085
2019
Q2
$918K Buy
38,194
+28,477
+293% +$674K 0.01% 1061
2019
Q1
$230K Buy
+9,717
New +$224K ﹤0.01% 1978

Other funds holding HNDL

Cambridge Investment Research Advisors's HNDL Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Strategy Shares Nasdaq 7HANDL Index ETF (HNDL) stake by 4.9% in Q2 2026, buying an estimated $451K and bringing the position to 426,309 shares worth $9.74M. The position accounts for 0.02% of the portfolio, ranked #692.

Cambridge Investment Research Advisors first reported a position in HNDL in Q1 2019 and has held it in 30 quarters since. 103 funds tracked by Wall St. Rank hold HNDL as of Q2 2026.

  • Cambridge Investment Research Advisors held 426,309 shares of Strategy Shares Nasdaq 7HANDL Index ETF worth $9.74M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 19,917 Strategy Shares Nasdaq 7HANDL Index ETF shares in Q2 2026, an estimated $451K.
  • Strategy Shares Nasdaq 7HANDL Index ETF made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #692 holding.
  • Cambridge Investment Research Advisors first reported a position in Strategy Shares Nasdaq 7HANDL Index ETF in Q1 2019 and has held it in 30 quarters since.
  • 103 funds tracked by Wall St. Rank held Strategy Shares Nasdaq 7HANDL Index ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.